Structural requirements for enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck

To understand the mechanism(s) by which p56lck participates in T-cell receptor (TCR) signalling, we have examined the effects of mutations in known regulatory domains of p56lck on the ability of F505 p56lck to enhance the responsiveness of an antigen-specific murine T-cell hybridoma. A mutation of the amino-terminal site of myristylation (glycine 2), which prevents stable association of p56lck with the plasma membrane, completely abolished the ability of F505 p56lck to enhance TCR-induced tyrosine protein phosphorylation. Alteration of the major site of in vitro autophosphorylation, tyrosine 394, to phenylalanine diminished the enhancement of TCR-induced tyrosine protein phosphorylation by F505 p56lck. Such a finding is consistent with the previous demonstration that this site is required for full activation of p56lck by mutation of tyrosine 505. Strikingly, deletion of the noncatalytic Src homology domain 2, but not of the Src homology domain 3, markedly reduced the improvement of TCR-induced tyrosine protein phosphorylation by F505 Lck. Additional studies revealed that all the mutations tested, including deletion of the Src homology 3 region, abrogated the enhancement of antigen-triggered interleukin-2 production by F505 p56lck, thus implying more stringent requirements for augmentation of antigen responsiveness by F505 Lck. Finally, it was also observed that expression of F505 p56lck greatly increased TCR-induced tyrosine phosphorylation of phospholipase C-gamma 1, raising the possibility that phospholipase C-gamma 1 may be a substrate for p56lck in T lymphocytes. Our results indicate that p56lck regulates T-cell antigen receptor signalling through a complex process requiring multiple distinct structural domains of the protein.

[1]  M. Fournel,et al.  Differential regulation of T cell antigen responsiveness by isoforms of the src-related tyrosine protein kinase p59fyn , 1992, The Journal of experimental medicine.

[2]  T. Pawson,et al.  Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains. , 1992, Oncogene.

[3]  A. Veillette,et al.  Src-related protein tyrosine kinases and T-cell receptor signalling. , 1992, Trends in genetics : TIG.

[4]  J. Bolen,et al.  The src family of tyrosine protein kinases in hemopoietic signal transduction , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  W. Knapp,et al.  GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. , 1991, Science.

[6]  Arthur Weiss,et al.  The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Jove,et al.  Molecular features of the viral and cellular Src kinases involved in interactions with the GTPase-activating protein , 1991, Molecular and cellular biology.

[8]  R. Abraham,et al.  T-cell antigen receptor ligation induces tyrosine phosphorylation of phospholipase C-gamma 1. , 1991, The Journal of biological chemistry.

[9]  A. Weiss,et al.  Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-gamma 1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Rhee,et al.  CD3 stimulation causes phosphorylation of phospholipase C-gamma 1 on serine and tyrosine residues in a human T-cell line. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Perlmutter,et al.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.

[12]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[13]  Sefton Bm.  The lck tyrosine protein kinase. , 1991 .

[14]  J. Parnes,et al.  The roles of CD4 and CD8 in T cell activation. , 1991, Seminars in immunology.

[15]  N. Abraham,et al.  The lymphocyte-specific tyrosine protein kinase p56lck. , 1991, Seminars in immunology.

[16]  J. Parnes,et al.  Adhesion versus coreceptor function of CD4 and CD8: role of the cytoplasmic tail in coreceptor activity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Klausner,et al.  T cell antigen receptor activation pathways: The tyrosine kinase connection , 1991, Cell.

[18]  N. Abraham,et al.  Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck , 1991, Nature.

[19]  J. Parsons,et al.  Transformation by pp60src or stimulation of cells with epidermal growth factor induces the stable association of tyrosine-phosphorylated cellular proteins with GTPase-activating protein , 1991, Molecular and cellular biology.

[20]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[21]  N. Abraham,et al.  The lymphocyte-specific tyrosine protein kinase p56lck. , 1991, Seminars in immunology.

[22]  G. Carpenter,et al.  Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation. , 1990, Science.

[23]  T Pawson,et al.  Src homology region 2 domains direct protein-protein interactions in signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Abraham,et al.  Activation of p56lck through mutation of a regulatory carboxy-terminal tyrosine residue requires intact sites of autophosphorylation and myristylation , 1990, Molecular and cellular biology.

[25]  G. Schieven,et al.  Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Fournel,et al.  The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation. , 1990, Oncogene.

[27]  G. Mills,et al.  Tyrosine phosphorylation is an obligatory event in IL-2 secretion. , 1990, Journal of immunology.

[28]  K. Luo,et al.  Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site , 1990, Molecular and cellular biology.

[29]  T. Mustelin,et al.  T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. , 1990, Science.

[30]  J. Bolen,et al.  Alterations in tyrosine protein phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor of T lymphocytes , 1989, Molecular and cellular biology.

[31]  M. Moran,et al.  The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function , 1989, Molecular and cellular biology.

[32]  R. Klausner,et al.  T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. , 1989, The Journal of biological chemistry.

[33]  J. Cunningham,et al.  A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection , 1989, Cell.

[34]  L. Samelson,et al.  Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck , 1989, Nature.

[35]  J. Bolen,et al.  Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation , 1988, Molecular and cellular biology.

[36]  C. Rudd,et al.  The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Amrein,et al.  Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific tyrosine protein kinase, p56lck, reveals its oncogenic potential in fibroblasts. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Bolen,et al.  Post-translational alterations of the tyrosine kinase p56lck in response to activators of protein kinase C. , 1988, Oncogene research.

[39]  B. Sefton,et al.  Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. , 1988, Oncogene.

[40]  R. Kriz,et al.  Sequence similarity of phospholipase C with the non-catalytic region of src , 1988, Nature.

[41]  Jonathan A. Cooper,et al.  Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck) , 1988, Molecular and cellular biology.

[42]  B. Sefton,et al.  Expression of a new tyrosine protein kinase is stimulated by retrovirus promoter insertion , 1986, Nature.

[43]  E. Krebs,et al.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA , 1985, Cell.

[44]  H. Rammensee,et al.  Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. , 1985, Journal of immunology.

[45]  A. Reske-Kunz,et al.  Insulin‐specific T cell hybridomas derived from (H‐2b × H‐2k)F1 mice preferably employ F1unique restriction elements for antigen recognition , 1985, European journal of immunology.

[46]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[47]  E. Krebs,et al.  Phosphorylation of synthetic peptides by a tyrosine protein kinase from the particulate fraction of a lymphoma cell line. , 1982, Proceedings of the National Academy of Sciences of the United States of America.